Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Magdi Elsallab · SciRah

Researcher profile · Semantic Scholar

Magdi Elsallab

Share profile

Magdi Elsallab — researcher profile on SciRah

h-index: 10
Works: 27
Citations: 831

Most-cited papers

Scalable Manufacturing of CAR T cells for Cancer Immunotherapy
Mohamed Abouelenein, Magdi Elsallab, S. Feldman, A. Fesnak +5 more
2021Blood Cancer Discovery238 citations Open access
Semantic Scholar
Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell‐Based Interventions
G. Bauer, Magdi Elsallab, Mohamed Abouelenein
2018Stem Cells Translational Medicine135 citations Open access
Semantic Scholar
Second Primary Malignancies After Commercial CAR T Cell Therapy: Analysis of FDA Adverse Events Reporting System (FAERS).
Magdi Elsallab, Moataz Ellithi, M. Lunning, Christopher R. D'Angelo +4 more
2024Blood119 citations Open access
Semantic Scholar
Expanding access to CAR T cell therapies through local manufacturing
Magdi Elsallab, Marcela V. Maus
2023Nature Biotechnology71 citations
Semantic Scholar
CAR T-cell product performance in haematological malignancies before and after marketing authorisation
Magdi Elsallab, B. Levine, A. Wayne, Mohamed Abouelenein
2020The Lancet Oncology62 citations Open access
Semantic Scholar
Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals
Magdi Elsallab, C. Bravery, A. Kurtz, Mohamed Abouelenein
2020Molecular Therapy: Methods & Clinical Development52 citations Open access
Semantic Scholar
Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis
Magdi Elsallab, Moataz Ellithi, S. Hempel, H. Abdel-Azim +1 more
2023Cancer Gene Therapy49 citations Open access
Semantic Scholar
Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS Data.
Moataz Ellithi, Magdi Elsallab, M. Lunning, S. Holstein +6 more
2024Transplantation and Cellular Therapy39 citations Open access
Semantic Scholar
Post-marketing safety and efficacy surveillance of cell and gene therapies in the EU: A critical review
Enrico Fritsche, Magdi Elsallab, Michaela Schaden, S. Hey +1 more
201914 citations
Semantic Scholar
ACT To Sustain: Adoptive Cell Therapy To Sustain access to non-commercialized genetically modified cell therapies
Rebecca A. Gardner, Claire White, Magdi Elsallab, Stephanie Farnia +14 more
2024Transplantation and Cellular Therapy10 citations Open access
Semantic Scholar
CAR NK-92 cell–mediated depletion of residual TCR+ cells for ultrapure allogeneic TCR-deleted CAR T-cell products
Jonas Kath, Wei-Jie Du, S. Martini, Magdi Elsallab +10 more
2023Blood Advances10 citations Open access
Semantic Scholar
National Survey of FACT-Accredited Cell Processing Facilities: Assessing Preparedness for Local Manufacturing of Immune Effector Cells.
Magdi Elsallab, Florence T. Bourgeois, M. V. Maus
2024Transplantation and Cellular Therapy8 citations Open access
Semantic Scholar
Detection of SARS‐CoV‐2‐specific memory B cells to delineate long‐term COVID‐19 immunity
C. Thieme, Mohamed Abouelenein, Enrico Fritsche, M. Anft +16 more
2021Allergy. European Journal of Allergy and Clinical Immunology8 citations Open access
Semantic Scholar
Mapping the Clinical Development Trajectory of Cell and Gene Therapy Products
Magdi Elsallab, Michelle Ouvina, A. Arfé, Florence T. Bourgeois
2024Clinical pharmacology and therapy6 citations Open access
Semantic Scholar
Linking Scattered Stem Cell-Based Data to Advance Therapeutic Development.
A. Kurtz, Magdi Elsallab, R. Sanzenbacher, Mohamed Abouelenein
2019Trends in Molecular Medicine6 citations
Semantic Scholar
Comparison of Clinical Evidence Submitted to the FDA and EMA for Cell and Gene Therapies.
Magdi Elsallab, Sandra Gillner, Florence T. Bourgeois
2025JAMA Internal Medicine4 citations
Semantic Scholar
Charting the course for CAR T-cell manufacturing
Magdi Elsallab, Marcela V. Maus
2024Blood Advances4 citations Open access
Semantic Scholar
In vivo gene therapy with CAR-T cells.
D. Wagner, Magdi Elsallab, Marcela V. Maus
2026Blood1 citations
Semantic Scholar
Triple base-edited dual targeting CD70/33 CAR T cells to avoid cytokine-mediated resistance in Acute Myeloid Leukemia
A. Bratt, G. Martin, M. Phillips, Sophia E. Nigrovic +8 more
2025Blood1 citations
Semantic Scholar
Postmarketing safety profile of chimeric antigen receptor (CAR) T cell therapies in diffuse large B-cell lymphoma (DLBCL): Analysis of real-world (RW) AE reporting from the FDA Adverse Event Reporting System (FAERS).
M. Lunning, M. Maus, Moataz Ellithi, F. Toron +5 more
2025Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Microfluidic T-Chip enables one-step clinical-scale T-cell purification from blood products for CAR T-cell manufacturing
Maheen Rana, Sophia E. Nigrovic, Adriana Payan-Medina, Sarthak Saha +8 more
2026bioRxiv0 citations Open access
Semantic Scholar
Rational Engineering of Notch1 Signaling to Boost the Proliferation of CD19-BBζ CAR-T.
M. Phillips, F. Birocchi, Felix Korell, Diego Salas-Benito +14 more
2026Blood0 citations
Semantic Scholar
Gene regulatory elements determine efficacy of BCMA-targeted CAR-T cell products
V. Blumenberg, Kristen B. June, F. Birocchi, Giulia Escobar +14 more
2026Journal for ImmunoTherapy of Cancer0 citations Open access
Semantic Scholar
Safety Profile of Chimeric Antigen Receptor T-cell Therapies in Diffuse Large B-cell Lymphoma: An Analysis of Real-World Adverse Event Reporting From the FDA Adverse Event Reporting System
Magdi Elsallab, M. Lunning, Moataz Ellithi, F. Toron +5 more
2026Mayo Clinic Proceedings: Innovations, Quality & Outcomes0 citations Open access
Semantic Scholar
Assessment of United States Food and Drug Administration Approval of Cell and Gene Therapies
Mahnum Shahzad, Magdi Elsallab, M. Siebert, Florence T. Bourgeois
2026Clinical pharmacology and therapy0 citations Open access
Semantic Scholar
265 Augmenting notch1 to enhance CD19-BBz CAR-T therapy
M. Phillips, F. Birocchi, Felix Korell, Diego Salas-Benito +15 more
2025Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Decentralizing gene and cell therapy manufacturing: changing tides or uphill battle
Magdi Elsallab
2024Cell and Gene Therapy Insights0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Mohamed Abouelenein×9
Invite
Mohamed Abouelenein — researcher profile on SciRah
Moataz Ellithi×5
Invite
Moataz Ellithi — researcher profile on SciRah
M. Lunning×4
Invite
M. Lunning — researcher profile on SciRah
Marcela V. Maus×4
Invite
Marcela V. Maus — researcher profile on SciRah

Invite

M. Phillips — researcher profile on SciRah

Invite

F. Birocchi — researcher profile on SciRah

Invite

M. Leick — researcher profile on SciRah

Marcela V. Maus×3

Invite

Marcela V. Maus — researcher profile on SciRah

Invite

Adele Mucci — researcher profile on SciRah

Amanda A. Bouffard×3

Invite

Amanda A. Bouffard — researcher profile on SciRah

Yue-Yang Fan×3

Invite

Yue-Yang Fan — researcher profile on SciRah

Trisha R. Berger×3

Invite

Trisha R. Berger — researcher profile on SciRah